SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-024290
Filing Date
2023-05-25
Accepted
2023-05-25 17:05:19
Documents
14
Period of Report
2023-05-25
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rlay-20230525.htm   iXBRL 8-K 52762
2 EX-99.1 rlay-ex99_1.htm EX-99.1 43207
3 GRAPHIC img175089203_0.jpg GRAPHIC 7375
  Complete submission text file 0000950170-23-024290.txt   226434

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rlay-20230525.xsd EX-101.SCH 2454
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rlay-20230525_lab.xml EX-101.LAB 12806
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rlay-20230525_pre.xml EX-101.PRE 9443
8 EXTRACTED XBRL INSTANCE DOCUMENT rlay-20230525_htm.xml XML 4526
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39385 | Film No.: 23961888
SIC: 2836 Biological Products, (No Diagnostic Substances)